tm
Seeing Is Believing
tm
Seeing Is Believing
MXCT is currently covered by 1 analysts with an average price target of $5. This is a potential upside of $5.47 (320.17%) from yesterday's end of day stock price of $1.19.
MaxCyte's activity chart (see below) currently has 23 price targets and 20 ratings on display. The stock rating distribution of MXCT is 100% BUY.
Highest price target for MXCT is $5, Lowest price target is $5, average price target is $5.
Most recent stock forecast was given by from CRAIG HALLUM on 25-Mar-2026. First documented stock forecast 24-Aug-2021.
Currently out of the existing stock ratings of MXCT, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Mar-2026
$5
$3.76 (303.23%)
$7
5 months 17 days ago
(25-Mar-2026)
0/2 (0%)
$4.31 (624.64%)
Buy Since 24-Aug-2021
$5
1 years 1 months ago
(11-Aug-2025)
0/6 (0%)
$2.57 (105.76%)
Buy Since 24-Aug-2021
$9
$7.76 (625.81%)
$11
1 years 5 months 30 days ago
(12-Mar-2025)
0/3 (0%)
$5.82 (183.02%)
Buy Since 24-Aug-2021
$11
$9.76 (787.10%)
$11
2 years 4 months 19 days ago
(23-Apr-2024)
0/6 (0%)
$7.2 (189.47%)
Buy
$12
$7.98 (198.51%)
$12
2 years 11 months 6 days ago
(05-Oct-2023)
0/4 (0%)
$9.4 (361.54%)
Which analyst most recently updated their price target on MXCT (MaxCyte)?
Which analyst has the current lower performing score on MXCT (MaxCyte) with a proven track record?
Which analyst has the most public recommendations on MXCT (MaxCyte)?
Which analyst is the currently most bullish on MXCT (MaxCyte)?
Which analyst is the currently most reserved on MXCT (MaxCyte)?
